Our Pricing

Understanding Wegovy's Fifth Dose (1.7mg) and UK Availability

The wegovy 5th dose in stock uk represents a critical milestone in your weight management journey, marking the transition to the 1.7mg maintenance phase. At Cured Pharmacy, we maintain consistent stock of Wegovy's fifth dose (1.7mg) to ensure you can progress through your treatment plan without interruption, supported by our UK-registered clinical team and superintendent pharmacist Tarun Kumar (GPhC 2233073).

What Is the Wegovy 5th Dose In Stock UK and Why It Matters

The wegovy 5th dose in stock uk refers to the 1.7mg strength administered during weeks 17-20 of your semaglutide treatment protocol. This dose represents the penultimate step in Wegovy's graduated titration schedule, designed to minimise gastrointestinal side effects whilst optimising weight loss outcomes[1]. Clinical trials demonstrate that patients who successfully reach and maintain this dose experience significantly greater weight reduction compared to those who discontinue earlier.

Stock availability of Wegovy's fifth dose has been a concern across UK pharmacies due to global supply constraints, making it essential to work with a pharmacy that maintains reliable inventory. At Cured Pharmacy, we prioritise stock management for all Wegovy doses to prevent treatment interruptions that could compromise your progress. Our system alerts patients when their next dose is due, ensuring seamless continuation from the 1.0mg fourth dose to the 1.7mg fifth dose[2].

How to Order Wegovy 5th Dose In Stock UK from Cured Pharmacy

Ordering the wegovy 5th dose in stock uk from Cured Pharmacy requires completion of a brief online clinical assessment reviewed by our UK-registered prescribers. The process typically takes under three minutes and evaluates your current weight, BMI, previous Wegovy doses, any side effects experienced, and contraindications. This assessment ensures the 1.7mg dose remains appropriate for your individual circumstances and that you've tolerated the earlier titration phases adequately.

Once approved, your Wegovy 1.7mg prescription is dispensed from our GPhC-registered pharmacy (9012511) and dispatched via next-day delivery in 100% discreet packaging. We provide transparent pricing at £69.00 per dose, with new patients eligible for £20 off their first order using code Weightlossnew. All Wegovy supplied is genuine, UK-licensed medication sourced directly from authorised wholesalers, never grey-market imports.

Clinical Assessment Requirements for the Fifth Dose

Our prescribers specifically assess whether you've completed the full titration schedule (0.25mg for 4 weeks, 0.5mg for 4 weeks, 1.0mg for 4 weeks, and 1.7mg for 4 weeks) before progressing to the fifth dose. Patients who've experienced severe nausea, vomiting, or other gastrointestinal effects at lower doses may require additional consultation before advancing to 1.7mg[3]. We also verify that you're achieving meaningful weight loss, defined as at least 5% body weight reduction after 16 weeks of treatment, in accordance with NICE guidance.

Wegovy 5th Dose In Stock UK: Expected Results and Clinical Evidence

Clinical data from the STEP trials show that patients reaching the wegovy 5th dose in stock uk phase (1.7mg) typically experience cumulative weight loss of 10-12% of their initial body weight by week 20[1]. This dose maintains therapeutic semaglutide levels sufficient to reduce appetite, slow gastric emptying, and improve glycaemic control in those with prediabetes or type 2 diabetes. The fifth dose serves as preparation for the final maintenance dose of 2.4mg, which delivers the maximum approved therapeutic effect.

It's important to recognise that individual responses vary considerably. Some patients achieve excellent results at the 1.7mg fifth dose and experience minimal additional benefit from progressing to 2.4mg, whilst others require the full maintenance dose for optimal outcomes[4]. Our clinical team monitors your progress through follow-up assessments, adjusting your treatment plan based on weight loss trajectory, tolerability, and any emerging health considerations.

Managing Side Effects at the Fifth Dose

The most commonly reported side effects at the 1.7mg wegovy 5th dose in stock uk strength include nausea (affecting approximately 20-25% of patients), diarrhoea, constipation, and occasional headache[2]. These effects are generally mild to moderate and diminish over the four-week period at this dose. We recommend injecting Wegovy at the same time each week, staying well-hydrated, eating smaller portions, and avoiding high-fat meals to minimise gastrointestinal discomfort. Patients experiencing persistent vomiting or signs of pancreatitis (severe abdominal pain radiating to the back) should contact our clinical team immediately.

Wegovy 5th Dose In Stock UK Pricing and Value Comparison

At Cured Pharmacy, the wegovy 5th dose in stock uk is priced at £69.00, representing the cheapest UK price for genuine, licensed Wegovy 1.7mg pens. This transparent pricing includes your clinical consultation, prescription, and next-day delivery, with no hidden fees or subscription commitments. New patients can reduce their first order to £69.00 by applying code Weightlossnew at checkout, providing £20 off as an introductory offer.

When evaluating cost, it's essential to consider the total treatment journey rather than individual dose pricing. Most patients require approximately 5-6 months to complete the full Wegovy titration and reach maintenance dosing, with the fifth dose representing weeks 17-20 of this protocol. We offer ongoing support throughout your treatment, including medication reminders, clinical check-ins, and access to our pharmacist team for questions about administration, storage, or side effects.

Stock Availability and Supply Chain for Wegovy 5th Dose In Stock UK

The wegovy 5th dose in stock uk has faced intermittent supply challenges since Wegovy's UK launch, with manufacturer Novo Nordisk prioritising allocation to patients already established on treatment. At Cured Pharmacy, we maintain strategic stock reserves of all Wegovy doses, including the 1.7mg fifth dose, through our relationships with multiple licensed wholesalers. This multi-source approach ensures we can fulfil prescriptions even during periods of sector-wide shortage.

We implement a patient priority system that guarantees existing Wegovy patients receive their next dose before new patient allocations, preventing treatment interruptions that could necessitate restarting the titration schedule. If you're currently on the 1.0mg fourth dose and approaching week 17, we recommend placing your fifth dose order at least one week in advance to ensure seamless progression. Our pharmacy team monitors stock levels daily and proactively contacts patients if any supply concerns arise.

What to Do If Your Fifth Dose Is Unavailable

In the rare event that the wegovy 5th dose in stock uk becomes temporarily unavailable, clinical guidance permits remaining at your current dose (1.0mg) for an extended period rather than interrupting treatment entirely[3]. Some patients may be suitable for switching to alternative GLP-1 receptor agonists such as Saxenda (liraglutide) or Mounjaro (tirzepatide), though this requires fresh clinical assessment. Our prescribers evaluate these options individually, prioritising continuity of your weight management programme whilst ensuring safety and regulatory compliance.

Wegovy 5th Dose In Stock UK: Administration and Storage Guidelines

The wegovy 5th dose in stock uk is supplied as a pre-filled, single-use injection pen containing 1.7mg semaglutide in 0.75ml solution. Administer the injection once weekly, on the same day each week, into the abdomen, thigh, or upper arm using the provided pen device. The injection technique remains identical to previous doses, though you may notice the pen delivers a slightly larger volume than the earlier 0.25mg and 0.5mg doses. Rotate injection sites each week to prevent lipohypertrophy (fatty lumps under the skin) that can affect absorption[4].

Store unopened Wegovy pens in the refrigerator at 2-8°C, away from the freezer compartment. Once in use, the pen may be kept at room temperature (below 30°C) or continued in the refrigerator for up to 6 weeks with the pen cap on. Never use a Wegovy pen that has been frozen, even if subsequently thawed, as freezing denatures the semaglutide protein and renders it ineffective. If you miss your scheduled dose, take it as soon as you remember if fewer than 5 days have passed; otherwise, skip that dose and resume your normal schedule the following week.

Scientific References

1. Wilding, J. P., Batterham, R. L., Calanna, S., Davies, M., Van Gaal, L. F., Lingvay, I., ... & Kushner, R. F. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002. [accessed 15 August 2026]
2. Rubino, D., Abrahamsson, N., Davies, M., Hesse, D., Greenway, F. L., Jensen, C., ... & Wadden, T. A. (2021). Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: the STEP 4 randomized clinical trial. JAMA, 325(14), 1414-1425. [accessed 15 August 2026]
3. Garvey, W. T., Batterham, R. L., Bhatta, M., Buscemi, S., Christensen, L. N., Frias, J. P., ... & Wharton, S. (2022). Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature Medicine, 28(10), 2083-2091. [accessed 15 August 2026]
4. Novo Nordisk. (2023). Wegovy 1.7mg solution for injection in pre-filled pen: Summary of Product Characteristics. Electronic Medicines Compendium. [accessed 15 August 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 15 August 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 15 August 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 15 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.